Skip to content

ANNE Diagnostic Agreement With Home Sleep Testing

Low Burden Wearable Sensor System for Diagnosing Obstructive Sleep Apnea Over Multiple Nights: Diagnostic Agreement With Home Sleep Testing

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05421754
Enrollment
38
Registered
2022-06-16
Start date
2022-01-06
Completion date
2023-02-28
Last updated
2023-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea of Adult

Brief summary

The main objective of this study is to provide an adequately powered study that would provide evidence on the non-inferiority of ANNE to a Home Sleep Test (HST).

Detailed description

The main objective of this study is to provide an adequately powered study that would provide evidence on the non-inferiority of ANNE to a Home Sleep Test (HST) for the diagnosis of moderate to severe OSA. Other study objectives include: * Determining diagnostic yield from multiple nights and better usability compared to current HST in the intended population. This will include all subjects and a focus on olders 65 and older. * Gathering participant feedback on the use of the sensors and use of the application elicited through focus groups

Interventions

ANNE Sleep system for 1 night with HST followed by 3 nights of ANNE Sleep system alone.

Sponsors

Sibel Health Inc.
CollaboratorINDUSTRY
Northwestern University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

Patients will use ANNE Sleep system with Home Sleep Testing (HST) during one night followed by three subsequent nights with the ANNE Sleep system alone.

Eligibility

Sex/Gender
ALL
Age
22 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 22 years old. * Subjects with suspected OSA based on history and physical. Subjects with self-reported symptoms of OSA based on the STOP-Bang questionnaire indicating affirmative answers to any of the following: snoring, daytime fatigue/sleepiness/tiredness, partners who have observed the subject stopping breathing or choking/gasping during sleep. Persons with a previous diagnosis of OSA are also eligible. * Willingness to give written consent and comply with study procedures

Exclusion criteria

-An unstable medical condition, acute or chronic, that in the opinion of the investigator puts the subject at health risks related to this trial or interferes with the clinical trial and data collection based on the opinion of the investigator, this includes but is not limited to: A. Significant cardiorespiratory disease: patients that are oxygen dependent, previous hospitalization for cardiorespiratory issues, or left ventricular ejection fraction ≤ to 40% B. Respiratory muscle weakness due to a neuromuscular condition C. Awake hypoventilation or suspicion of sleep related hypoventilation D. Chronic opioid medication use E. History of stroke F. History of severe insomnia * Inability to understand instructions * Has a skin abnormality that precludes assessment * Has a history of dementia * Patients with implanted pacemakers or defibrillators

Design outcomes

Primary

MeasureTime frameDescription
Percent Agreement of ANNE Sleep System to Home Sleep Test (WatchPAT) for Diagnostic Performance to Detect Moderate to Severe Obstructive Sleep Apnea.4 nightsTo determine the percent agreement between the ANNE sleep system to a Home Sleep Test (WatchPAT) for diagnostic performance to positively detect moderate to severe obstructive sleep apnea.. The WatchPAT system and ANNE sleep were worn for a single night together. The ANNE sleep system was additionally analyzed for up to 3 multiple nights and the data from those nights was pooled to compare against WatchPAT system for positively detecting moderate to severe obstructive sleep apnea.

Countries

United States

Participant flow

Pre-assignment details

Thirty-eight participants consented to the study and thirty participants started the study. Eight participants decided not to participate before any study procedures or were lost to follow-up after the consent process.

Participants by arm

ArmCount
ANNE Sleep
After consent, subjects will wear the ANNE Sleep system with HST for 1 night and 3 nights with ANNE sleep system alone. ANNE Sleep: ANNE Sleep system for 1 night with HST followed by 3 nights of ANNE Sleep system alone.
30
Total30

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyTechnical issue with sensor1

Baseline characteristics

CharacteristicANNE Sleep
Age, Continuous48.4 years
STANDARD_DEVIATION 15.3
Anxiety4 Participants
Asthma2 Participants
Body Mass Index (BMI)28.2 kg/m^2
STANDARD_DEVIATION 3.9
Depression6 Participants
Epworth Sleepiness Scale8 units on a scale
Hypertension8 Participants
Race/Ethnicity, Customized
Race : Asian
8 participants
Race/Ethnicity, Customized
Race : Black or African American
1 participants
Race/Ethnicity, Customized
Race : Did not answer
3 participants
Race/Ethnicity, Customized
Race : Hispanic or Latino
2 participants
Race/Ethnicity, Customized
Race : White
19 participants
Sex/Gender, Customized
Sex
Did not answer
3 Participants
Sex/Gender, Customized
Sex
Female
10 Participants
Sex/Gender, Customized
Sex
Male
17 Participants
Type II Diabetes2 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 30
other
Total, other adverse events
0 / 30
serious
Total, serious adverse events
0 / 30

Outcome results

Primary

Percent Agreement of ANNE Sleep System to Home Sleep Test (WatchPAT) for Diagnostic Performance to Detect Moderate to Severe Obstructive Sleep Apnea.

To determine the percent agreement between the ANNE sleep system to a Home Sleep Test (WatchPAT) for diagnostic performance to positively detect moderate to severe obstructive sleep apnea.. The WatchPAT system and ANNE sleep were worn for a single night together. The ANNE sleep system was additionally analyzed for up to 3 multiple nights and the data from those nights was pooled to compare against WatchPAT system for positively detecting moderate to severe obstructive sleep apnea.

Time frame: 4 nights

ArmMeasureGroupValue (NUMBER)
ANNE SleepPercent Agreement of ANNE Sleep System to Home Sleep Test (WatchPAT) for Diagnostic Performance to Detect Moderate to Severe Obstructive Sleep Apnea.Single night58 percent agreement
ANNE SleepPercent Agreement of ANNE Sleep System to Home Sleep Test (WatchPAT) for Diagnostic Performance to Detect Moderate to Severe Obstructive Sleep Apnea.Multiple nights75 percent agreement

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026